Udayavni Special

WHO says ‘more information’ required from Bharat Biotech for emergency use listing of Covaxin


PTI, May 25, 2021, 8:04 AM IST

The World Health Organisation (WHO) said “more information” is “required” from Bharat Biotech, which is seeking emergency use listing (EUL) for its Covaxin vaccine for COVID-19.

The latest ‘Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process’ guidance document dated May 18 on the WHO website said Bharat Biotech submitted EOI (Expression of Interest) on April 19 and that “More information required”. A pre-submission meeting is expected “to be planned May-June 2021,” the guidance document said.

According to the WHO, submissions to it for prequalification or listing under the emergency use procedure are confidential.

If a product submitted for assessment is found to meet the criteria for listing, WHO will publish the results widely. Duration of the emergency use listing process depends on the quality of the data submitted by the vaccine manufacturer and on those data meeting WHO criteria, according to the agency.

Meanwhile, Bharat Biotech International Limited (BBIL) has conveyed to the government that it has already submitted 90 per cent of documents to WHO for obtaining emergency use listing (EUL) for the Covaxin vaccine, sources said on Monday.

The remaining documents are expected to be submitted by June, the Hyderabad-based Bharat Biotech Ltd told the Central government during a discussion on obtaining the World Health Organisation’s authorisation for emergency use listing for Covaxin, sources said.

”BBIL is confident about obtaining WHO’s emergency use listing,” said a source.

Noting that Covaxin has already received regulatory approval from 11 countries, sources said there was also interest from other 11 companies in seven nations for technology transfer and production of Covaxin. The company is in the final stages of negotiations with the Food and Drug Administration of the US for conducting small-scale phase-III clinical trials of Covaxin in the United States, sources said.

Sources said the meeting with BBIL on the EUL was attended by the company’s managing director V Krishna Mohan and his colleagues besides senior officers of the Ministry of Health, Department of Biotechnology and Ministry of External Affairs. Foreign Secretary Harsh Vardhan Shringla was among those who attended the meeting.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Chhetri extends contract with Bengaluru FC for another two years

Bengaluru: 5 people try to sacrifice 10-yr-old to ‘ward off spirits’; arrested

Don’t be under illusion that COVID-19 is gone, CM BSY’s warns as restrictions ease

‘Vaccination hesitation is coronavirus invitation’: Naqvi at launch of awareness campaign

Man given two doses of COVID vaccine in 30 minutes duration

SC asks Centre if PM-headed NDMA decided on ex-gratia compensation to families of COVID victims

Facebook, WhatsApp urge HC to stay CCI notice in privacy policy matter



Related Articles More

Daily COVID-19 count in India lowest in 88 days

Dakshina Kannada second major COVID-19 hotspot for a day

COVID: The three barriers that stop people being vaccinated

I’ll be alright in 3-4 days: Milkha’s first response after contracting COVID

K’taka reported 2,856 black fungus cases till date: Official

MUST WATCH

Yoga at Work Place

Udayavani News Bulletin 20-JUN-2021

Manipal IT youngsters plants trees | Planting trees to preserve the Environment

Police Sub Inspector angry on Farmers in Raichur

Belgaum Rescue operation

Latest Additions

Net profit of big cement firms surges 29.6% in pandemic-hit FY21: Report

When Madhavrao Scindia staged a ‘dacoity’ to spook Indian cricket stars

Chhetri extends contract with Bengaluru FC for another two years

Iran’s president-elect defends himself over 1988 executions

Bengaluru: 5 people try to sacrifice 10-yr-old to ‘ward off spirits’; arrested

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.